Merck
CN
Search Within
Document Type

2403-88-5

Applied Filters:
Keyword:'2403-88-5'
Showing 1-5 of 5 results for "2403-88-5" within Technical Documents
GR 144053- Non-peptide antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) fibrinogen receptor
., et al., J. Leukoc. Biol., 68, 31-37 (2000). 60. Baker, J.E., et al., Mol. Cell. Biol., 21, 2393-2403 (2001). 61. Horiba, M., et al., J. Clin. Invest., 105, 489-497 (2000). 62. Qi, M., et al., J. Biol
Protein Tyrosine Phosphatases- Potential Roles in Disease
19 (1996). 5. Neel, B.G. and Tonks, N.K., Curr. Opin. Cell Biol., 9, 193-204 (1997). 6. Adachi, M., et al., Cell, 85, 15-23 (1996). 7. Yang, Q. and Tonks, N.K., Proc. Natl. Acad. Sci. USA, 88, 5949-5953
Pellicon® Capsules with Ultracel® Membrane
1288 1627 2915 PCC030C45G 4.5 1665 2307 3972 PCC030C45L 1683 2316 3999 PCC030C45E 1857 2403 4260 Conclusion Hold-up volumes in the feed channel of Pellicon® Capsules were characterized to
Pellicon® Capsules with Ultracel® Membrane
1288 1627 2915 PCC030C45G 4.5 1665 2307 3972 PCC030C45L 1683 2316 3999 PCC030C45E 1857 2403 4260 Conclusion Hold-up volumes in the feed channel of Pellicon® Capsules were characterized to
Diabetes and Obesity
formation in vascular smooth muscle cells.  Composition: 88-95% lipid; 5-12% protein.  Purity: ≥95% of total lipoprotein content by electrophoresis. 5 mg Apolipoproteins and Lipoproteins (continued)